Izotropic Corporation and its wholly owned U.S. operating subsidiary, Isotropic Imaging Corp. (IIC), have assembled a management team, board of directors, and advisory team consisting of world-class scientists, highly experienced physicians, and business leaders with long histories of building companies and bringing products to market.

Board of Directors

Robert (Bob) Thast
Chief Executive Officer

In the past 30 years, Thast has served as board chairman, chief executive officer, senior executive, and director of a number of publicly traded companies. He has extensive knowledge of capital markets, financing activities, and company management. Thast has a track record of raising and attracting venture, early stage, and operating capital, and has personally raised more than $200 million for companies he directed, managed, or consulted for. Through his experience building and managing companies, Thast has also developed expertise in strategic planning, business development, finance, and contract negotiations, as well as all aspects of legal, accounting, corporate governance, and regulatory requirements related to public companies.

John M. Boone, Ph.D.,
Inventor, Chief Science Officer, Director 

Boone is a medical physicist with 32 years of experience in academia, with broad interests in medical imaging, computed tomography, and breast computed tomography. He has been the principal investigator of the Breast Tomography Project at the University of California, Davis for the past 18 years, and his laboratory has been at the forefront of the academic development of breast CT technology. Boone is professor of radiology and biomedical engineering, and recently served as president of the American Association of Physicists in Medicine (AAPM), the principal medical physics organization in the U.S. He is co-author of the medical imaging textbook, Essential Physics of Medical Imaging. Boone has also authored more than 200 peer-reviewed papers and holds 13 U.S. patents.

Boone earned his Ph.D. in medical physics and is board certified by the American Board of Radiology in diagnostic radiological imaging. He is a fellow of the American Association of Physicists in Medicine, American College of Radiology, Society of Breast Imaging, American Institute for Medical and Biological Engineering (AIMBE), and SPIE (the international society for optics and photonics). Boone is also a commissioner of the International Commission on Radiation Units (ICRU). 

D. Barry Lee
Chief Financial Officer

Lee has extensive experience in corporate senior management. During the last 24 years, Lee has served as CFO and COO of several publicly held companies and provided strategic planning, financial control, corporate governance, and M&A expertise for both public and private companies.

Marshall (Terry) Severyn
Vice President of Marketing, Director

Severyn has more than 30 years’ experience in corporate sales and marketing. He has successfully led teams from six to more than 1,000 employees in the pharmaceutical and high-tech arenas. Severyn began his career in a sales management position with Perdue Pharma, which led to a director’s position with Norwich Eaton Pharmaceuticals, Proctor and Gamble Pharma, and SISU. His focus was launching products globally in the areas of gastroenterology, urogynecology, bone disease, and immunology. Severyn has also held senior management positions with Telus, Bell Canada, and Rogers Communications, where he led major sales organizations and new product development.

Ali Sodagar
Legal Advisor, Director

Sodagar founded Sodagar & Company Law Corp. in 2005, a multidiscipline law firm specializing in international business, project finance, mergers and acquisition, corporate, real estate, intellectual property, and trademark law. Sodagar specializes in business and commercial law, intellectual property, trademark, copyright, and licensing law.

In addition to his background in law, Mr. Sodagar holds a bachelor’s degree in medical & health physics and a master’s degree in medical biophysics. As part of his master’s program, Sodagar worked on a CT with a C-arm for arterial and contrast-enhanced imaging. Sodagar earned his LL.B. from Western University in Ontario and an LL.B. in European law from the University of Amsterdam. Mr. Sodagar has been a registered Trademark Agent (License #14799) since January 2005.

Scientific Advisory Board

The following advisors are leaders in the field of breast cancer research, imaging technology development, market approvals, and business development. The company continues to search for strategic advisors and meaningful alliances that will demonstrate the company’s commitment to scientific excellence.

Martin Yaffe, Ph.D.
Senior Advisor

Dr. Yaffe is currently a senior scientist in physical sciences at Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Ontario. He is also a professor of medical imaging and medical biophysics at the University of Toronto.

His appointments include: (1) Tory Family Chair in cancer research, Sunnybrook Health Sciences Centre; (2) director, smarter imaging program, Ontario Institute for Cancer Research; (3) co-director, imaging translation program, Ontario Institute for Cancer Research; (4) chief scientific officer, Centre for Imaging Technology Commercialization of Research; and, (5) member of the Order of Canada.

Yaffe’s research focus is digital imaging for medical diagnosis and disease management. His research is directed toward developing and improving imaging techniques for detecting, diagnosing, and treating cancer, with a strong focus on breast cancer. His team is also interested in methods for analyzing image patterns to predict breast cancer risk and using these as tools to study the causes of breast cancer and to help develop preventive measures. Activities in the lab range from creating image processing strategies for assessing and improving the quality of diagnostic images, to developing and evaluating tomosynthesis imaging and contrast-enhanced imaging methods. His team has established a comprehensive program in biomarker imaging research, which includes developing new techniques for 3-D pathology. These techniques will be used for validation of new in vivo imaging methods, as well as for investigating approaches for improving pathology accuracy, and adding prognostic and predictive information in the management of cancer.

Yaffe is a fellow of the American Association of Physicists in Medicine and an honorary fellow of the Society of Breast Imaging.

Karen Lindfors, M.D.
Senior Breast Imaging Radiologist & Clinical Advisor

Dr. Lindfors is a leading expert in the field of breast cancer screening and breast imaging and diagnostics, having specialized in cancer radiology and breast imaging and diagnostic radiology for more than 30 years. She is highly published and a leading advocate for women’s health who works locally and nationally to promote patient and healthcare professional education for early detection of breast cancer. Dr. Lindfors has been the lead clinical researcher in developing new methods to screen for breast cancer, including dedicated breast CT developed at UC Davis and breast tomosynthesis.

Lindfors is a board-certified radiologist who began her career with an internship and residency at Massachusetts General Hospital in Boston from 1979 to 1983, followed by a fellowship at Harvard in 1984. She joined the staff at UC Davis Medical Center in 1985 and retired in June 2017 as chief of breast imaging and professor of clinical radiology.

Lindfors is a fellow of the American College of Radiology. She is also a member of the American Roentgen Ray Society, California Radiological Society, Northern California Radiological Society, Radiological Society of North America, and Society of Breast Imaging.

Norbert Pelc, Ph.D.
Senior Development & Technology Advisor

Pelc is a professor of bioengineering and radiology at Stanford University. From 2012 to 2017, he was chair of the university’s department of bioengineering. Prior to joining the Stanford faculty in 1990, Pelc was senior physicist and manager of the applied sciences laboratory at GE Medical Systems where he developed technology for all medical imaging modalities.

His primary research interests are in the physics, engineering, and mathematics of diagnostic imaging, along with the development of applications of this imaging technology. His current work focuses on computed tomography, specifically in methods to improve information content and image quality and to reduce the radiation dose from these examinations.

Pelc is a member of the National Academy of Engineering and a fellow of the American Association of Physicists in Medicine, the International Society for Magnetic Resonance in Medicine, SPIE (the international society for optics and photonics), and the American Institute of Medical and Biological Engineering. Pelc served on the first National Advisory Council of the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health.

Dr. Craig Shimasaki, Ph.D., MBA
Medical Device Business Consultant

Shimasaki is founder and CEO of BioSource Consulting Group, a technology commercialization organization that translates innovative discoveries through the development process into commercial products. He is a serial entrepreneur with over 33 years of biotechnology industry experience, starting his career at Genentech. He co-founded nine biotech companies and led five clinical diagnostic tests through FDA 510(k) approval. He is a co-inventor on several patents and has been involved in raising over $60 million for these companies and participated in taking five companies public in the Canadian and U.S. Markets. His expertise is in key aspects of start-ups to mid-size biotechnology companies. Shimasaki’s experience includes company formation, technology and IP licensing, virtual business models, product development expertise in diagnostics, medical device, biologics and therapeutics sectors, raising angel and VC capital, clinical testing, regulatory approval, marketing and branding, employee development and organizational design.

Dr. Shimasaki has authored and edited two books “The Business of Bioscience: What Goes Into Making a Biotechnology Product”and “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies.” Dr. Shimasaki received his BS in Biochemistry from University of California at Davis, his PhD in Molecular Biology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business. He an Adjunct Professor at the University of Oklahoma, Price School of Business and teaches biotechnology entrepreneurship.